Latest "BioMedical Enterprises, Inc." News Stories

07:29 EDT 23rd May 2018 | BioPortfolio

Here are the most relevant search results for "BioMedical Enterprises, Inc." found in our extensive news archives from over 250 global news sources.

More Information about BioMedical Enterprises, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about BioMedical Enterprises, Inc. for you to read. Along with our medical data and news we also list BioMedical Enterprises, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioMedical Enterprises, Inc. Companies for you to search.

Showing "BioMedical Enterprises" News Articles 1–25 of 2,000+

Wednesday 23rd May 2018

Measuring Flow of Low Viscosity Fluids

Based on a radial flow technique, Titan Enterprises turbine flowmeter range provides the ideal way for accurately measuring the flow of low viscosity liquids. Classic turbine flowmeters use propeller type turbines in a closed circular conduit. The turbine is mounted on low friction bearings and its rotation is detected through the chamber wall by one of a variety of detector types...

Hood College, Frederick National Laboratory Will Renew Popular Scientific Symposium

Partnership will include research, training and professional development opportunities FREDERICK, Md. (PRWEB) May 23, 2018 Hood College and the Frederick National Laboratory for Cancer Research have partnered to cohost an annual scientific symposium in the tradition of the landmark Oncogene Meeting, a national fixture in Frederick for more than 20 years. A recently signed, three-year Memorandum o...

Carol Monaghan, MP, Parliamentary Questions on ME/CFS and Biomedical Research Funding | 23 May 2018

The Minister of State for Health and Social Care responds to biomedical research question.

Tuesday 22nd May 2018

WuXi Biologics to Invest S$80 Million to Establish a Biologics Manufacturing Facility in Singapore

- WuXi Biologics' first overseas site in Asia SINGAPORE and SHANGHAI, May 22, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, today announced that it is to invest S$80 million (equivalent to approximately USD$...

Seven New York City-Area Scientists Win Pershing Square Sohn Prize for Young Investigators in Cancer Research

The Pershing Square Sohn Research Alliance Has Invested $19 million in the Next Generation of New York City Medical Research Talent to Accelerate Breakthroughs in Cancer Research The Pershing Square Sohn Cancer Research Alliance today announced the seven winners of the 2018

Schizophrenia - A Pipeline Analysis Report | Technavio

Technavio has announced its new research report on the drug development pipeline for

PPD, Evidera join NEWDIGS Initiative at MIT as a Strategic Partner

Collaboration to drive innovation across health care ecosystem Pharmaceutical Product Development, LLC (PPD), and its real-world research and market access business unit, Evidera, have joined the Massachusetts Institute of Technology Center for Biomed

Independent Study Reveals Software AG’s Digital Business Platform Delivers 324% ROI and a Six-Month Payback Period

Software AG (Frankfurt TecDAX:SOW) today announced the significant return on investment businesses could realize by implementing the Software AG Digital Business Platform. According to The

Global Sodium Acetate Market - High Demand from APAC| Technavio

Technavio projects the global sodium acetate market to post a CAGR of over 7% during the forecast p

The next generation toolkit in the tough fight against cancer: targeting, personalisation and collaboration are key

Today’s guest blog comes from María José Lallena, Director, Quantitative Biology. Alcobendas Biochemistry and Cell Biology Laboratory, Lilly Spain and #WeWontRest ambassador. I work at Lilly’s R&D centre in Alcobendas in Spain with over 100 other scientists. Most of us, including myself, work in oncology. While cancer continues to cause so much suffering and grief, it may seem surpris...

PPD, Evidera Join NEWDIGS Initiative at MIT

Collaboration aims to develop solutions for industry wide obstacles to biomedical innovation

Contrasting Cardinal Health

Cardinal Health and Nu Skin Enterprises are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk. Cardinal Health pays an annual dividend of $1.85 per share and has a dividend yield of 3.5%.

Mergers and Acquisitions to Drive the Radiofrequency Ablation Devices Market | Technavio

Technavio market research analysts forecast the global radiofrequency ablation devices marke

Monday 21st May 2018

The nature of the Ebola virus responsible for the 9th epidemic currently raging in the DRC character

(INSERM (Institut national de la santé et de la recherche médicale)) The National Institute for Biomedical Research (INRB) of Kinshasa and Inserm have characterized the nature of the Ebola virus responsible for the 9th epidemic currently raging in the Democratic Republic of Congo (DRC). The strain identified is the so-called Ebola Zaire strain.Identify the virus circulating in RDC represented a ...

The case for not taxing multinationals

(Bocconi University) The habit of taxing Multinational Enterprises (MNEs)' profits is the legacy of a time when "GM had to make cars in Detroit and Hollywood had to make movies in L.A.", but is now inefficient and detrimental to global welfare, a new study by Nicolai Foss, Rodolfo Debenedetti Chair of Entrepreneurship at Bocconi University, and colleagues asserts. The solution would be zeroing cor...

Scioto Biosciences Closes $1.8M in Series A Financing, Receives NIH and State of Indiana Grants Funding to Support Launch of New Microbiome Platform Technology

Scioto Biosciences, a preclinical stage company developing innovative therapies to transform the delivery of microbiome therapeutics, today announced it has closed on $1.8M in Series A financing to support the launch of its new microbiome platform technology. The funding represents a first-time interstate collaboration between two Indiana-b...

Automated External Defibrillator Market - Technological Advances to Promote Growth| Technavio

Technavio market research analysts forecast the global automated external defibrillator ma

Top Insights on the Animal Feed Trace Minerals Market | Technavio

Technavio’s latest market research report on the global animal feed trace minerals market

Chagas Disease - A Pipeline Analysis Report| Technavio

Technavio has announced its pipeline analysis report on Chagas disease. The report comprises an in-depth analysis of t

Panasonic Announces Autism Sprint Car Sponsorship to Raise Autism Spectrum Disorder Awareness

Funded by Panasonic, the Autism Sprint Car Will Compete in North Carolina, South Carolina and Virginia Panasonic System Solutions Company of North America, Division of Panasonic Corporation of North America, today announced its sponsorship of the

The Copley Consulting Group Powers Digital Transformation for Seven New Customers

Record Setting Quarter Indicates Need for Next-Generation ERP Solution for Small to Midsize Manufacturing Organizations WOBURN, Mass. (PRWEB) May 21, 2018 The Copley Consulting Group, an Infor Gold level Channel partner, announced the signing of seven new clients this past month, as part of the Infor fiscal year which ended on April 30, 2018. The new clients range from single product start-ups to...

SetPoint Medical Appoints Ankit Shah to Lead Commercialization and Marketing

– Commercialization Expertise Beneficial as SetPoint Advances its Clinical Program – SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced today the appointment of Ankit Shah as Senior Director of Commercialization and Marketing. Mr. Shah has more than a...

Infinitus (China) Re-Accredited as a National High-Tech Enterprise of China for the Fourth Time

GUANGZHOU, China, May 21, 2018 /PRNewswire/ -- Recently, Infinitus (China) Company Ltd. (Infinitus (China)) has been accredited as 2017 National High-Tech Enterprise of China for three years since November 9, 2017. Infinitus (China) has been recognized as National High-Tech Enterprise for the fourth time along with its first accreditation in 2008.

GC Pharma to Establish Curevo - a Seattle-based New Company Dedicated to Development of New Vaccines

GC Pharma, IDRI and MIBR Bringing Together to Develop Innovative Vaccines YONGIN, South Korea, May 20, 2018 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced the establishment of Curevo Inc. ("Curevo"). The newly established Seattle-based company's goal...

Researchers Create a 3-D Printed Smart Gel That Walks Underwater, Moves Objects

The new technology has biomedical, soft robot and other applications

Quick Search


News Quicklinks